Search Within
Content Type
Applications
Vaccine manufacturing
Applied Filters:
facet applications:Vaccine manufacturing
Showing 1-30 of 31 results
BIO International
We warmly invite you to visit booth 4735 at BIO International and connect with the MilliporeSigma team.
Bioprocessing Summit
Vaccine processing evolution focuses on agile manufacturing solutions amid the COVID pandemic.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Virus-Based Vaccine Manufacturing
Tailored viral vaccine manufacturing addresses virus-specific challenges through collaboration.
mRNA Vaccines and Therapeutics Manufacturing
mRNA vaccine technology offers rapid development and scalable manufacturing for disease prevention.
Plasmid DNA Vaccines Manufacturing
Learn about overcoming challenges in manufacturing pDNA vaccines, including low productivity and separation issues.
Protein Subunit Vaccine Manufacturing
This page provides an overview of protein subunit vaccines, which incorporate a recombinant protein fragment derived from the viral pathogen. It includes a description of the subunit vaccine manufacturing workflow and the products and technologies that are essential to ensure
Virus-like Particles (VLPs) Vaccine Manufacturing
VLP vaccine manufacturers must optimize upstream productivity with reliable scale-up, achieve yield and efficiency goals with robust impurity removal, maximize downstream recovery, and ensure patient safety.
Viral Vector Vaccine Mfg
A templated process produces live vector vaccines. Challenges: yield loss, filtration, aggregation, scaling. Collaboration overcomes manufacturing hurdles.
Estrategias de fabricación de vacunas y terapias de ARNm
La tecnología del ARNm ofrece versatilidad terapéutica; sus sistemas de administración inducen la producción de proteínas para diversas aplicaciones.
Coronavirus (SARS-CoV-2) Viral Proteins
SARS-CoV-2 structural proteins: envelope (E), membrane (M), nucleocapsid (N), spike (S). Explore related reagents for research.
Fabricación de vacunas
Desde las primeras etapas del desarrollo hasta la producción de la vacuna a gran escala, pasando por la purificación de las últimas etapas: obtenga más información sobre el desarrollo de procesos de vacunas y la experiencia en la aplicación.
Fabricación de vacunas basadas en virus
La fabricación de vacunas víricas a medida aborda los retos específicos del virus mediante la colaboración.
Fabricación de vacunas y terapias de ARNm
La tecnología de las vacunas de ARNm ofrece un desarrollo rápido y una fabricación escalable para la prevención de enfermedades.
Fabricación de vacunas de ADN plasmídico
Obtenga información sobre cómo superar las dificultades en la fabricación de vacunas de ADNp, como los problemas de baja productividad y de separación.
Fabricación de vacunas de subunidades proteicas
Esta página proporciona una visión general de las vacunas de subunidades proteicas, que incorporan un fragmento de proteína recombinante procedente del patógeno vírico. Incluye una descripción del procedimiento de fabricación de vacunas de subunidades y los productos y tecnologías que
Fabricación de vacunas de subunidades proteicas
Esta página proporciona una visión general de las vacunas de subunidades proteicas, que incorporan un fragmento de proteína recombinante procedente del patógeno vírico. Incluye una descripción del procedimiento de fabricación de vacunas de subunidades y los productos y tecnologías que
Fabricación de vacunas de partículas similvíricas (VLP)
Los fabricantes de vacunas VLP deben optimizar la productividad upstream con un escalado fiable, alcanzar los objetivos de rendimiento y eficiencia con una eliminación sólida de impurezas, maximizar la recuperación downstream y garantizar la seguridad del paciente. La cartera integrada
Producción de vacunas vectoriales víricas
Un proceso basado en plantillas produce vacunas de vectores vivos. Retos: pérdida de rendimiento, filtración, agregación, escalado. La colaboración supera los obstáculos de la fabricación.
Cell Harvest, Lysis, Neutralization and Clarification of Plasmid DNA (pDNA) for mRNA, plasmid-based DNA Vaccines, and Viral Vector applications
An overview of the cell harvest, lysis, neutralization, and clarification steps used for pDNA purification along with case study and practical advice.
Plasmid DNA Purification Process
Free eBook outlines plasmid DNA manufacturing process and downstream purification challenges for various applications.
Cost Modeling Vaccine Manufacturing: Estimate Production Costs for mRNA and other Vaccine Modalities
A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.
Egg-based and Cell-based Influenza Vaccine Manufacturing Methods
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
Eshmuno® Fit Custom Affinity Resin Development Services: Frequently Asked Questions
This page answers all the frequently asked questions related to our Eshmuno® Fit custom affinity resin development services.
Formulation Strategies for mRNA Vaccines and Therapeutics
Discover efficient strategies for formulating mRNA, including information on lipid selection, lipid nanoparticles, and excipients for optimal stability.
Manufacturing Strategies for mRNA Vaccines and Therapeutics
mRNA technology offers therapeutic versatility; its delivery systems induce protein production for various applications.
mRNA Synthesis for the Development of Vaccines and Therapeutics
Understand how mRNA vaccines induce immunity. and read how synthetic mRNA is prepared for vaccine immunogens and other biopharmaceuticals. Find reagents for synthesis of mRNA.
Virus-like Particle (VLP) Vaccine Bioprocessing and Formulation Steps
This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
In this webinar, we present a comparison of novel technologies, discuss key considerations for manufacturing, and share selected case studies for platforms such as virus-like-particles, viral vectors, plasmid DNA, and mRNA platforms.
Personalized T cell therapy for HBV and HCC
This webinar explores challenges and strategies in T cell engineering for promising cancer immunotherapy options.
Page 1 of 2